(Q34109564)

31 July 2017

title

Elevated sympathetic nerve activity in patients with accelerated essential hypertension (English)

1 reference

malignant essential hypertension

31 July 2017

main subject

1 reference

Matsukawa T

1

1 reference

31 July 2017

Mano T

series ordinal

2

1 reference

31 July 2017

Gotoh E

series ordinal

3

1 reference

31 July 2017

Ishii M

series ordinal

4

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 July 1993

1 reference

Journal of Clinical Investigation

31 July 2017

published in

1 reference

31 July 2017

volume

92

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

25-28

1 reference

Aldosterone secretion and primary and malignant hypertension

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Adrenergic Facilitation by Angiotensin: Does it Serve a Physiological Function?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Cardiovascular effects of angiotensin mediated by the central nervous system

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

On the central hypertensive effect of angiotensin II.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Predisposing factors for the development of malignant essential hypertension.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Role of sympathetic nervous system activity in the blood pressure response to long-term captopril therapy in severely hypertensive patients.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

Effects of intravenous infusions of angiotensin II on muscle sympathetic nerve activity in humans

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=293521

The action of angiotensin and bradykinin on the superior cervical ganglion of the cat

28 October 2018

1 reference

12 December 2020

Increased plasma renin substrate concentration in human malignant hypertension

1 reference

12 December 2020

Further Studies on the Hypernoradrenergic State of Treated Hypertensives: Effect of Captopril

1 reference

12 December 2020

Atropine and a hypertensive crisis

1 reference

12 December 2020

Sequential changes in urinary catecholamine in the transition from benign to malignant hypertension in rats

1 reference

12 December 2020

Angiotensin II inhibits baroreflex control of muscle sympathetic nerve activity and the heart rate in patients with essential hypertension

1 reference

12 December 2020

1 reference

12 December 2020

Augmented sympathetic nerve activity in response to stressors in young borderline hypertensive men

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI116558

1 reference

31 July 2017

1 reference

31 July 2017

1 reference